Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) Peptid
PLA2G4B
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN939674
Kurzübersicht für Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) Peptid (ABIN939674)
Target
PLA2G4B
(Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- KDHYENLYCV VSGEKHFLFH PPSDRPFIPY ELYTPATYQL TEEGTFKVVD
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PLA2 G2 antibody,
Alternative Names: PLA2G4B control peptide, PLA2G4B antibody Blocking Peptide, Anti-PLA2G4B Blocking Peptide, phospholipase A2, group IVB, cytosolic Blocking Peptide, FLJ42498 Blocking Peptide, HsT16992 Blocking Peptide, cPLA2-beta Blocking Peptide, PLA2G4B, PLAG4B-2, PLAG4B 2, PLAG4B-2 Blocking Peptide, PLAG4B 2 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
-
Hintergrund
- This gene transcribes naturally-occurring mRNAs that are co-transcribed products of the neighboring JMJD7 and PLA2G4B genes. Incompletely processed read-through transcripts from these two loci are abundantly expressed in most tissues, but the function of the predicted protein product has not yet been determined. Alternative splicing of this gene results in different transcript variants, some of which are candidates for nonsense-mediated decay (NMD).
-
Molekulargewicht
- 114 kDa
Target
-
Sie sind hier:
